Trial Profile
Study of ABSORB Stent in Acute Coronary Syndrome
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms ABSORB-ACS
- 24 Mar 2014 New trial record